|
| |
Overview
Financial Highlight
Headlines
Business Background K-One Technology Bhd engages in the research, design, and development of electronic end-products and sub-systems for the communication, computer, and consumer electronics industries. It operates through following segments: Research, Design, Development, and Sales; Manufacturing; and Investment Holding. The Research, Design, Development, and Sales segment involves electronic end products and subsystems for the communication, computer and consumer electronics industries and service sales. The Manufacturing segment which contributes majority revenue offers electronic end products, sub-systems, wire-harness, and electronic related accessories. The Investment Holding segment consists of dormant companies.
  Win288288 strong collection 0.115, MACD just nice drawing, anytime soon will fly. 29/06/2022 4:16 PM Finewood How Easily Can K-One Technology Berhad Raise Cash? While K-One Technology Berhad seems to be in a fairly good position, it's still worth considering how easily it could raise more cash, even just to fuel faster growth. Companies can raise capital through either debt or equity. Commonly, a business will sell new shares in itself to raise cash and drive growth. By looking at a company's cash burn relative to its market capitalisation, we gain insight on how much shareholders would be diluted if the company needed to raise enough cash to cover another year's cash burn. K-One Technology Berhad's cash burn of RM11m is about 11% of its RM96m market capitalisation. As a result, we'd venture that the company could raise more cash for growth without much trouble, albeit at the cost of some dilution. 30/06/2022 11:39 PM Finewood https://vaxine.net/tga-grants-provisional-determination-to-vaxine-for-its-covid-19-recombinant-protein-vaccine/ 30/06/2022 11:46 PM Finewood Debt Level: K1 is debt free. Reducing Debt: K1 had no debt 5 years ago. 03/07/2022 12:11 PM Finewood Volume should improve in 2 weeks time. Consolidating mode. New investor funds needed. K1 not aggressive enough in marketing effort.. 03/07/2022 1:32 PM Finewood With the RM weakening 6% again the greenback considering K1 major client is overseas, it should be a good sign to accumulate 08/07/2022 9:18 AM MaluNegaraKu Stay tune for the next historical low price soon.... This share already reach Mars long time ago..... Will reach another galaxy soon 14/07/2022 9:16 AM Finewood A new low for no peculiar reason is understated. No changes in management team, no losses in the past quarter. Revenue increase, ready cash for any potential acquisition. Covid cases going up, but no lockdown. USD at ATH, these are all positive reasons for the share to spike up in the 2H of the year TP rm0.49 Mid Term, rm0.75 Long Term 16/07/2022 3:13 PM MaluNegaraKu This share talk number 1 - MOU, NASA, PPE - but no outcome! Just like some of us - talk 3 talk cock 18/07/2022 1:15 PM Finewood Debate is only healthy if it’s based on facts. Investment is long term, don’t be clouded by current negative sentiment. Is the global market, not particularly a single stock. Name shaming is the lowest in the hierarchy.. 18/07/2022 9:10 PM MaluNegaraKu Fact need to prove by outcome , a company with zero outcome and numerous MoU that never materialize is like day dreaming 26/07/2022 3:32 PM Finewood MOU is an exploration of opportunity. Doesn’t necessarily translate to sales. Cash flow is the blood in the veins and K1 has it for bigger acquisition plans. 26/07/2022 10:48 PM Finewood Q6. At what stage (may be in term of percentage) the development on the ventilator has achieved? How much MIDA Grant has been utilised as at to date? A6. The development of the ventilator is progressing well. As it is a Class C medical device, i.e. a semi-invasive medical device, it needs to go through numerous clinical trials/tests to ensure that it is safe for use. Therefore, the management would need to work on this with care and have collaborated with 2 prestigious universities in Malaysia to conduct the tests on the ventilator which would be branded as “Medkaire”. Once the clinical trials are completed in the next few months, the application to MDA for its final approval would be submitted. Applications in conjunction with clinical trials are planned for submission for FDA and CE approvals which are necessary for the export markets. The development of the ventilator has taken a long time as it must ensure that the device is safe for use as safety is of utmost importance. The ventilator business is for long term and does not depend on COVID- 19 only as the device can be used for other respiratory diseases or in aiding breathing difficulty. The Company is thankful for the MIDA Grant. It is progressing well and the management had submitted claims for work done based on milestones achieved. 02/08/2022 9:49 AM moonasia anyone know K one got make any profit from this test kid? https://klse.i3investor.com/web/blog/detail/ceomorningbrief/2022-08-18-story-h1627981734-K_One_Unit_Gets_Conditional_Approval_Extension_to_Distribute_Covid_19_T 19/08/2022 8:45 AM MaluNegaraKu When world wide finish sold and market with overloaded ventilator, then K1 will launch their prototaip ventilator to the world . Malaysia-style Cakap no1, buat xtahu , duit bazir banyak 09/09/2022 12:16 PM Finewood https://www.thestar.com.my/business/business-news/2022/12/06/k-one-made-exclusive-distributor-of-diversey-products-in-malaysia 06/12/2022 11:05 PM  William Ng what good news? already no see this stock for 2 years , now active stock... 07/12/2022 3:00 PM 899999 beli kumul sementara.harga murah anak syarikat K1 ada lesen.Cloud Amazon ada kepentingan.dlm.AWS 04/03/2023 8:03 PM Eric Fong Can see K1 cloud service website here. Not bad, Many corporate customer. https://www.g-asiapac.com/ 05/03/2023 12:07 AM 899999 Eric Fong 感恩，谢谢分享 K1 G Asia Pacific ada Cloud lesen.drp AMAZON di banti.u.sd 3juta bantu melatih tenaga mahis high skiled Cloud tecnictionsetiap tahun.selama tiga tahun.berturut.....beli kumpul sementara harga.murah 05/03/2023 6:44 AM  | |
